HUMAN GENOME SCIENCES INC Operating Margin
- Operating margin · 12 months: Value -158.51%; Formula and calculation Operating income / revenue. Period ending 2012-06-30..
Operating margin
Overview →Financial period ending 2012-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Operating margin · 12 months | -158.51% | Operating income / revenue. Period ending 2012-06-30. $-296.43M ÷ $187.01M × 100 ≈ -158.51% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Operating income | -296.43M USD | Operating Income (Loss) |
| Revenue | 187.01M USD | |
| Cost of products and services | (m) | |
| Research and development | 153.30M USD | Research and Development Expense |
| Selling, general and administration | (m) | Selling, General and Administrative Expense |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Operating income (USD) | Revenue (USD) | Cost of products and services (USD) | Research and development (USD) | Selling, general and administration (USD) | Operating margin |
|---|---|---|---|---|---|---|
| 2012-06-30 | $-296.43M | $187.01M | (m) | $153.30M | (m) | -158.51% |
| 2012-03-31 | $-289.74M | $151.53M | (m) | $151.27M | (m) | -191.21% |
| 2011-12-31 | $-329.55M | $130.97M | (m) | $196.18M | (m) | -251.61% |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | $-290.50M | $123.47M | (m) | $205.40M | (m) | -235.27% |
| 2011-03-31 | $-269.00M | $137.41M | (m) | $223.38M | (m) | -195.76% |
| 2010-12-31 | $-190.77M | $157.35M | (m) | $196.37M | (m) | -121.24% |
| 2010-09-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-06-30 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-03-31 | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $6.19M | $275.75M | (m) | $173.71M | (m) | 2.24% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.